| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.494 | 8.440 | 12.477 | 13.326 | 27.713 | 20.471 | 33.504 | 35.340 | 46.765 | 41.172 |
| Total Income - EUR | 6.494 | 8.441 | 12.478 | 13.326 | 27.713 | 21.557 | 33.504 | 35.340 | 46.766 | 41.176 |
| Total Expenses - EUR | 9.356 | 11.302 | 9.142 | 6.317 | 11.695 | 11.911 | 10.957 | 15.105 | 17.687 | 23.067 |
| Gross Profit/Loss - EUR | -2.862 | -2.861 | 3.336 | 7.009 | 16.018 | 9.645 | 22.548 | 20.235 | 29.079 | 18.109 |
| Net Profit/Loss - EUR | -3.056 | -3.030 | 3.211 | 6.875 | 15.741 | 9.440 | 22.212 | 19.935 | 28.620 | 17.059 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Uromed Calancea Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 775 | 500 | 235 | 1.772 | 1.525 | 2.200 | 1.408 | 619 |
| Current Assets | 11.004 | 2.334 | 2.164 | 7.158 | 18.048 | 11.153 | 25.170 | 21.147 | 29.817 | 19.763 |
| Inventories | 1.470 | 0 | 0 | 0 | 1.351 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5 | 385 | 972 | 1.845 | 1.763 | 3.140 | 3.562 | 3.370 | 3.623 | 3.450 |
| Cash | 9.529 | 1.949 | 1.192 | 5.313 | 14.934 | 8.013 | 21.609 | 17.777 | 26.195 | 16.313 |
| Shareholders Funds | 10.630 | -2.974 | 287 | 7.157 | 17.436 | 9.572 | 23.060 | 21.722 | 28.742 | 17.294 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 375 | 5.309 | 2.652 | 501 | 847 | 3.353 | 3.635 | 1.624 | 2.484 | 3.087 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uromed Calancea Srl